Whitney R Grither
Overview
Explore the profile of Whitney R Grither including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mullen M, Grither W, Millimet H, Mutch D, Hagemann A, McCourt C, et al.
Gynecol Oncol Rep
. 2024 Sep;
55:101476.
PMID: 39229484
No prospective data have been described to inform guidelines on antibiotic prophylaxis for partial vulvectomies. Thus, we conducted a single-center, pilot, double-blind randomized controlled trial to assess the effectiveness of...
2.
Grither W, Baker B, Morikis V, Ilagan M, Fuh K, Longmore G
Mol Cancer Res
. 2024 Feb;
22(5):495-507.
PMID: 38334461
Implications: This study demonstrates that ROR2 in ovarian cancer cells is important for directed migration to the metastatic niche and provides a potential signaling axis of interest for therapeutic targeting...
3.
Grither W, Hagemann I, Powell M, Mullen M
Cancer
. 2023 Oct;
130(3):339-341.
PMID: 37902951
No abstract available.
4.
Schab A, Greenwade M, Stock E, Lomonosova E, Cho K, Grither W, et al.
Mol Cancer Res
. 2023 Aug;
21(11):1234-1248.
PMID: 37527178
Implications: DDR2 is highly expressed by stromal cells in ovarian cancer that can mediate metastasis and is a potential therapeutic target in ovarian cancer.
5.
Grither W, Dickson B, Fuh K, Hagemann I
Gynecol Oncol Rep
. 2020 Sep;
34:100636.
PMID: 32964092
Uterine tumor resembling ovarian sex cord tumor (UTROSCT) is a rare uterine neoplasm of uncertain malignant potential. We present the case of a 69-year-old woman who underwent hysterectomy for postmenopausal...
6.
Bayer S, Grither W, Brenot A, Hwang P, Barcus C, Ernst M, et al.
Elife
. 2019 May;
8.
PMID: 31144616
Biomechanical changes in the tumor microenvironment influence tumor progression and metastases. Collagen content and fiber organization within the tumor stroma are major contributors to biomechanical changes (e., tumor stiffness) and...
7.
Zhang K, Grither W, Van Hove S, Biswas H, Ponik S, Eliceiri K, et al.
J Cell Sci
. 2019 May;
132(9).
PMID: 31048546
No abstract available.
8.
Grither W, Longmore G
Proc Natl Acad Sci U S A
. 2018 Aug;
115(33):E7786-E7794.
PMID: 30061414
The action of the collagen binding receptor tyrosine kinase (RTK) discoidin domain receptor 2 (DDR2) in both tumor and tumor stromal cells has been established as critical for breast cancer...
9.
Grither W, Divine L, Meller E, Wilke D, Desai R, Loza A, et al.
Oncogene
. 2018 Jan;
37(13):1714-1729.
PMID: 29348456
The mesenchymal gene program has been shown to promote the metastatic progression of ovarian cancer; however, specific proteins induced by this program that lead to these metastatic behaviors have not...
10.
Corsa C, Brenot A, Grither W, Van Hove S, Loza A, Zhang K, et al.
Cell Rep
. 2016 Jun;
15(11):2510-23.
PMID: 27264173
High levels of collagen deposition in human and mouse breast tumors are associated with poor outcome due to increased local invasion and distant metastases. Using a genetic approach, we show...